trending Market Intelligence /marketintelligence/en/news-insights/trending/rR2wLrf8RhQNwrjT4LZ0pg2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Galena Biopharma, Cardinal Health settle product swap disputes

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Galena Biopharma, Cardinal Health settle product swap disputes

Galena Biopharma Inc. agreed to settle all of its outstanding disputes with Cardinal Health Inc. over a product swap agreement.

Under the deal, Galena Biopharma will pay $500,000 to Cardinal Health. In turn, Cardinal Health will destroy all of the Zuplenz product returned due to the product swap. The related product swap agreement was also terminated as of the settlement date.

The companies entered into the agreement Sept. 25.